Literature DB >> 15652531

Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture.

Boris V Stanzel1, Edgar M Espana, Martin Grueterich, Tetsuya Kawakita, Jean-Marie Parel, Scheffer C G Tseng, Susanne Binder.   

Abstract

The success of surgical removal of choroidal neovascularisation followed by transplantation of autologous retinal pigment epithelial cells (RPE) for age-related macular degeneration (ARMD) may be limited by damage in Bruch's membrane. We investigated whether amniotic membrane (AM) might be used as an alternative basement membrane-containing matrix to support RPE growth and differentiation. Primary RPE plastic cultures were established from freshly enucleated Dutch belted rabbit eyes in DMEM/F12 containing 0.1 mM Ca(++) and 10% dialysed FBS. Upon subconfluence, cells were subcultured at 5000-9000 cells cm(-2) in the above-mentioned culture medium on intact AM (iAM), epithelially denuded AM (dAM) or plastic. After confluence, the Ca(++) concentration in the medium was increased to 1.8 mm for 4 weeks. Growth and morphology were monitored by phase contrast microscopy, and the phenotype by immunostaining with antibodies against cytokeratin 18, tight junction protein ZO-1, and RPE65 protein, and by transepithelial resistance (TER) measurement. Immunostaining to cytokeratin 18 confirmed the epithelial origin of isolated cells in both primary culture and subcultures. Compared to plastic cultures, RPE increased pigmentation within 24 hr after seeding on AM, with iAM being more pronounced than dAM. RPE adopted a hexagonal epithelial phenotype with more organised pigmentation, strong expression of ZO-1 and RPE65, and a significantly higher TER 4 weeks after Ca(++) switch on dAM. Our results indicate that AM may be used as a basement membrane-containing matrix to maintain RPE phenotype in vitro, and may facilitate subsequent transplantation to treat ARMD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652531     DOI: 10.1016/j.exer.2004.06.032

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  16 in total

Review 1.  Retinal pigment epithelium differentiation of stem cells: current status and challenges.

Authors:  Basak E Uygun; Nripen Sharma; Martin Yarmush
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 2.  Studying melanin and lipofuscin in RPE cell culture models.

Authors:  Michael E Boulton
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

3.  Epidermal growth factor: the driving force in initiation of RPE cell proliferation.

Authors:  Kerstin Steindl-Kuscher; Michael E Boulton; Paulina Haas; Astrid Dossenbach-Glaninger; Hans Feichtinger; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

Review 4.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

Review 5.  Retinal pigment epithelial cell proliferation.

Authors:  Jeffrey Stern; Sally Temple
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-02

6.  Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo.

Authors:  Tadao Maeda; Mee Jee Lee; Grazyna Palczewska; Stefania Marsili; Paul J Tesar; Krzysztof Palczewski; Masayo Takahashi; Akiko Maeda
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

7.  Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells.

Authors:  William Samuel; Cynthia Jaworski; Olga A Postnikova; R Krishnan Kutty; Todd Duncan; Li Xuan Tan; Eugenia Poliakov; Aparna Lakkaraju; T Michael Redmond
Journal:  Mol Vis       Date:  2017-03-05       Impact factor: 2.367

Review 8.  Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.

Authors:  Nathan A Hotaling; Vladimir Khristov; Qin Wan; Ruchi Sharma; Balendu Shekhar Jha; Mostafa Lotfi; Arvydas Maminishkis; Carl G Simon; Kapil Bharti
Journal:  J Ocul Pharmacol Ther       Date:  2016-04-25       Impact factor: 2.671

9.  Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.

Authors:  Balendu Shekhar Jha; Kapil Bharti
Journal:  Curr Stem Cell Rep       Date:  2015-06

10.  Establishment of a human in vitro model of the outer blood-retinal barrier.

Authors:  R D Hamilton; A J Foss; L Leach
Journal:  J Anat       Date:  2007-10-08       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.